Attached files

file filename
EX-99.1 - EX-99.1 - Lantheus Holdings, Inc.d219054dex991.htm
8-K - FORM 8-K - Lantheus Holdings, Inc.d219054d8k.htm

Exhibit 99.2

LANTHEUS HOLDINGS, INC. AND SUBSIDARIES

UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET

JUNE 30, 2016

 

(in thousands, except share data)

   As Reported     Pro Forma
Adjustments (1)
    Pro Forma As
Adjusted
 

Assets

      

Current assets

      

Cash and cash equivalents

   $ 54,851      $ 1,237      $ 56,088   

Accounts receivable, net

     39,457        (1,639     37,818   

Inventory

     14,433        (394     14,039   

Other current assets

     4,282        (189     4,093   
  

 

 

   

 

 

   

 

 

 

Total current assets

     113,023        (985     112,038   

Property, plant and equipment, net

     84,422        (1     84,421   

Capitalized software development costs, net

     8,121        —          8,121   

Intangibles, net

     17,949        (260     17,689   

Goodwill

     15,714        —          15,714   

Other long-term assets

     20,038        (47     19,991   
  

 

 

   

 

 

   

 

 

 

Total assets

   $ 259,267      $ (1,293   $ 257,974   
  

 

 

   

 

 

   

 

 

 

Liabilities and Stockholders’ Deficit

      

Current liabilities

      

Line of credit

     —          —          —     

Accounts payable

     12,778        (489     12,289   

Accrued expenses and other liabilities

     17,664        (426     17,238   

Current portion of long-term debt

     3,650        —          3,650   
  

 

 

   

 

 

   

 

 

 

Total current liabilities

     34,092        (915     33,177   

Asset retirement obligations

     8,650        —          8,650   

Long-term debt, net

     348,838        —          348,838   

Other long-term liabilities

     34,055        82        34,137   
  

 

 

   

 

 

   

 

 

 

Total liabilities

     425,635        (833     424,802   
  

 

 

   

 

 

   

 

 

 

Commitments and contingencies

      

Stockholders’ deficit

      

Preferred stock

     —          —          —     

Common stock

     303        —          303   

Additional paid-in capital

     176,545        —          176,545   

Accumulated deficit

     (341,487     (1,041     (342,528

Accumulated other comprehensive loss

     (1,729     581        (1,148
  

 

 

   

 

 

   

 

 

 

Total stockholders’ deficit

     (166,368     (460     (166,828
  

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ deficit

   $ 259,267      $ (1,293   $ 257,974   
  

 

 

   

 

 

   

 

 

 

 

1


LANTHEUS HOLDINGS, INC. AND SUBSIDARIES

UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

SIX MONTHS ENDED JUNE 30, 2016

 

(in thousands, except per share data)

   As Reported     Pro Forma
Adjustments
(2)(3)
    Pro Forma As
Adjusted
 

Revenues

   $ 154,440      $ (4,834   $ 149,606   

Cost of goods sold

     84,988        (4,185     80,803   
  

 

 

   

 

 

   

 

 

 

Gross profit

     69,452        (649     68,803   
  

 

 

   

 

 

   

 

 

 

Operating expenses

      

Sales and marketing expenses

     19,150        (72     19,078   

General and administrative expenses

     18,751        (215     18,536   

Research and development expenses

     5,644        —          5,644   
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     43,545        (287     43,258   

Gain on sale of assets

     5,945        —          5,945   
  

 

 

   

 

 

   

 

 

 

Operating income

     31,852        (362     31,490   

Interest expense, net

     (13,996     —          (13,996

Other income, net

     454        45        499   
  

 

 

   

 

 

   

 

 

 

Income before income taxes

     18,310        (317     17,993   

Provision for income taxes

     637        33        670   
  

 

 

   

 

 

   

 

 

 

Net income

     17,673        (350     17,323   
  

 

 

   

 

 

   

 

 

 

Net income per common share:

      

Basic

   $ 0.58        $ 0.57   

Diluted

   $ 0.58        $ 0.57   

Weighted average common shares outstanding

      

Basic

     30,373          30,373   

Diluted

     30,454          30,454   

 

2


LANTHEUS HOLDINGS, INC. AND SUBSIDARIES

UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2015

 

(in thousands, except per share data)

   As Reported     Pro Forma
Adjustments
(2)(3)
    Pro Forma As
Adjusted
 

Revenues

   $ 293,461      $ (9,678   $ 283,783   

Cost of goods sold

     157,939        (7,977     149,962   
  

 

 

   

 

 

   

 

 

 

Gross profit

     135,522        (1,701     133,821   
  

 

 

   

 

 

   

 

 

 

Operating expenses

      

Sales and marketing expenses

     34,740        (134     34,606   

General and administrative expenses

     43,894        (322     43,572   

Research and development expenses

     14,358        —          14,358   
  

 

 

   

 

 

   

 

 

 

Total operating expenses

     92,992        (456     92,536   
  

 

 

   

 

 

   

 

 

 

Operating income

     42,530        (1,245     41,285   

Interest expense, net

     (38,691     —          (38,691

Loss on extinguisment of debt

     (15,528     —          (15,528

Other expense, net

     (89     (265     (354
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (11,778     (1,510     (13,288

Provision for income taxes

     2,968        (325     2,643   
  

 

 

   

 

 

   

 

 

 

Net loss

     (14,746     (1,185     (15,931
  

 

 

   

 

 

   

 

 

 

Net loss per common share:

      

Basic and diluted

   $ (0.60     $ (0.65

Weighted average common shares outstanding

      

Basic and diluted

     24,440          24,440   

 

(1) Pro Forma Adjustments represent: (a) cash proceeds of $1.5 million ($2.0 million AUD) less estimated transaction costs and (b) the related assets and liabilities that were included in the share purchase agreement.
(2) Pro Forma Adjustments represent the elimination of historical revenues and expenses contributing to consolidated results relating to the Australian subsidiary.
(3) Pro Forma Adjustments do not include revenues and expenses related to the long-term supply and distribution contract entered into by the Company and Global Medical Solutions, Ltd.

 

3